Previous Close | 0.1000 |
Open | 0.1000 |
Bid | 0.0000 |
Ask | 0.0500 |
Strike | 38.00 |
Expire Date | 2024-06-07 |
Day's Range | 0.1000 - 0.1000 |
Contract Range | N/A |
Volume | |
Open Interest | 47 |
PHILADELPHIA, June 07, 2024--US FDA approves expanded age indication for GSK’s AREXVY, the first respiratory syncytial virus (RSV) vaccine for adults aged 50-59 at increased risk
We recently compiled a list of 20 Cities With the Highest HIV/AIDS Rates in the US and in this article, we will talk about the city with the highest HIV/AIDS rates in the US. HIV Incidence and Prevalence in the United States The government of the United States has set a goal to reduce the […]
The simplest way to invest in stocks is to buy exchange traded funds. But one can do better than that by picking better...